INVIVO_RA_NONCANON

Non-canonical signalling pathways relayed by retinoic acid affecting germ cell differentiation

 Coordinatore CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE 

 Organization address address: Rue Laurent Fries 1
city: ILLKIRCH GRAFFENSTADEN
postcode: 67404

contact info
Titolo: Dr.
Nome: Steve
Cognome: Brooks
Email: send email
Telefono: 33388653394

 Nazionalità Coordinatore France [FR]
 Totale costo 261˙384 €
 EC contributo 261˙384 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2012-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-03-01   -   2015-06-20

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE

 Organization address address: Rue Laurent Fries 1
city: ILLKIRCH GRAFFENSTADEN
postcode: 67404

contact info
Titolo: Dr.
Nome: Steve
Cognome: Brooks
Email: send email
Telefono: 33388653394

FR (ILLKIRCH GRAFFENSTADEN) coordinator 261˙384.60

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

ra    according    invivo    vivo    diseases    differentiation    canonical    scientist    receptors    transcription    young    pathways    noncanon    signalling    rxr    vitro    action    rars    genes    cell    mechanisms    nsnr    data   

 Obiettivo del progetto (Objective)

'Cell proliferation, differentiation and death are controlled by different transcription factors amongst which the non-steroid nuclear receptors (nsNR). Deciphering the mechanisms of action of nsNR is a challenge in various research fields ranging from cancer and neurodegenerative disorders to metabolic diseases. According to the canonical signalling pathway liganded nsNR, in the form of dimers with a rexinoid receptor (RXR), bind to specific DNA response element of target genes and activate transcription. Retinoic acid (RA) receptors (RARs) belong to the nsNR family. RA is the active metabolite of vitamin A, which is indispensable for normal embryonic development and, postnatally, for survival, growth, reproduction and epithelial differentiation. Its properties to induce cell differentiation are used to treat diseases, from benign defects to cancers. According to in vitro data, RARs can act via several non canonical signalling pathways independently of RXR. The InVivo_RA_NonCanon project proposes to characterize such pathways in vivo, using the seminiferous epithelium of the testis as a model system. Working hypotheses have been constructed which integrate yet unpublished data aimed at uncovering genes differentially expressed in RA-deficient contexts and existing datasets identifying RAR binding sites genome wide. The experimental strategy will combine in vitro experiments to identify the mechanisms of action of RARs and in vivo genetic analyses, in the mouse, to test their functionality in a physiological context. Also, InVivo_RA_NonCanon aims at offering to a young scientist with an excellent scientific record, multi-disciplinary training and research experience in the field of cell biology with the goal of broadening the applicant’s skills in science on complementary subjects. The overall mission is to train the young researcher to become an independent scientist as well as to prepare him for a leading position in academia.'

Altri progetti dello stesso programma (FP7-PEOPLE)

EXPLICA (2009)

Exhaust Pipe noise radiation Modelling by Innovative Computational Aeroacoustics

Read More  

CELL THERAPY (2011)

Harnessing of hematopoietic stem cells for targeting of brain metastases

Read More  

HERODOT (2008)

"Heterogeneous quantum rod and quantum dot nanomaterials, towards a novel generation of photonic devices"

Read More